Cyclerion Therapeutics CYCN

$ 1.9 -9.09%

Quarterly report 2024-Q3
added 11-14-2024

Cyclerion Therapeutics Financial Statements 2011-2024 | CYCN

Annual Financial Statements Cyclerion Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	6.78 M	1.13 M	41.1 M	101 M	93.1 M	-	-	-	-	-	-	-	-
Shares	2.34 M	2.17 M	39.1 M	32.1 M	27.4 M	-	-	-	-	-	-	-	-
Historical Prices	2.9	0.52	1.05	3.84	4.28	-	-	-	-	-	-	-	-
Net Income	-5.26 M	-44.1 M	-51.6 M	-77.8 M	-123 M	-115 M	-93.9 M	-	-	-	-	-	-
Revenue	-	297 K	3.94 M	2.3 M	4.51 M	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	2.3 M	-	-	-	-	-	-	-	-	-
Operating Income	-13 M	-18.5 M	-55.2 M	-81.3 M	-125 M	-115 M	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-18.5 M	-54.7 M	-79 M	-122 M	-114 M	-92.2 M	-	-	-	-	-	-
Operating Expenses	13 M	18.8 M	59.1 M	85.2 M	130 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	8.13 M	12.9 M	20.6 M	28.8 M	34.4 M	27.5 M	15.1 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Cyclerion Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	2.53 M	2.51 M	2.49 M	2.47 M	2.44 M	2.28 M	2.18 M	2.18 M	2.17 M	2.17 M	43.4 M	43.4 M	43.3 M	35.7 M	34.1 M	34 M	32.1 M	27.8 M	27.7 M	27.6 M	27.4 M	27.4 M	27.4 K	-	27.4 K	27.4 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-723 K	-1.32 M	-1.54 M	-	7.57 M	-4.18 M	-6.95 M	-	-10.5 M	-13.4 M	-13 M	-	-11.3 M	-16.2 M	-13.4 M	-	-18.8 M	-19.5 M	-20.2 M	-	-27.3 M	-32.3 M	-37.4 M	-	-29.3 M	-29.8 M	-25.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	194 K	-	-	-	-	-	-	-	-	306 K	711 K	-	348 K	3 M	62 K	-	400 K	749 K	1.01 M	-	1.4 M	1.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-1.13 M	-1.38 M	-1.62 M	-	-6.02 M	-1.86 M	-3.28 M	-	-4.52 M	-13.4 M	-13 M	-	-11.3 M	-16.2 M	-13.4 M	-	-21.8 M	-19.7 M	-20.6 M	-	-28 M	-33.1 M	-37.4 M	-	-29.3 M	-29.8 M	-25.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-4.45 M	-13.4 M	-12.9 M	-	-10.9 M	-15.8 M	-13.1 M	-	-21.2 M	-19.1 M	-20 M	-	-27.3 M	-32.3 M	-36.9 M	-	-28.9 M	-29.4 M	-24.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	1.32 M	1.38 M	1.62 M	-	6.02 M	2.4 M	3.28 M	-	4.52 M	13.7 M	13.7 M	-	11.6 M	19.2 M	13.5 M	-	22.2 M	20.4 M	21.6 M	-	29.4 M	34.7 M	37.4 M	-	29.3 M	29.8 M	25.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.24 M	1.28 M	1.57 M	-	2.13 M	1.53 M	2.7 M	-	3.1 M	3.52 M	3.95 M	-	4.6 M	6.24 M	5.36 M	-	8.03 M	6.63 M	6.89 M	-	7.12 M	8.92 M	11 M	-	7.79 M	7.53 M	3.77 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency